fluorodopa f 18 has been researched along with Lymph Node Metastasis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bodner, G; Brammen, L; Karanikas, G; Koperek, O; Niederle, B; Niederle, MB; Riss, P; Scheuba, C; Selberherr, A | 1 |
Cabria, M; Cistaro, A; Conte, M; Garaventa, A; Lopci, E; Piccardo, A; Villavecchia, G | 1 |
Chang, HH; Hsu, WM; Jou, ST; Ko, CL; Ko, KY; Liu, CJ; Liu, YL; Lu, MY; Tzen, KY; Yang, YL; Yen, RF | 1 |
Brouwers, AH; de Vries, EG; Fiebrich, HB; Koopmans, KP | 1 |
Fogelman, I; Heinisch, M; Langsteger, W | 1 |
Hoegerle, S; Kraft, A; Moser, E; Nitzsche, EU; Schneider, B | 1 |
1 review(s) available for fluorodopa f 18 and Lymph Node Metastasis
Article | Year |
---|---|
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.
Topics: Bone Neoplasms; Breast Neoplasms; Choline; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
5 other study(ies) available for fluorodopa f 18 and Lymph Node Metastasis
Article | Year |
---|---|
Medullary Thyroid Carcinoma: Do Ultrasonography and F-DOPA-PET-CT Influence the Initial Surgical Strategy?
Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoma, Neuroendocrine; Child; Clinical Decision-Making; Dihydroxyphenylalanine; False Negative Reactions; False Positive Reactions; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Mediastinum; Middle Aged; Neck; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Tumor Burden; Ultrasonography; Young Adult | 2018 |
Bone and lymph node metastases from neuroblastoma detected by 18F-DOPA-PET/CT and confirmed by posttherapy 131I-MIBG but negative on diagnostic 123I-MIBG scan.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Dihydroxyphenylalanine; Humans; Lymphatic Metastasis; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
Risk Stratification of Pediatric Patients With Neuroblastoma Using Volumetric Parameters of 18F-FDG and 18F-DOPA PET/CT.
Topics: Adolescent; Child; Child, Preschool; Cone-Beam Computed Tomography; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Infant; Lymphatic Metastasis; Male; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients.
Topics: Adenocarcinoma; Aged; Carcinoid Tumor; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed | 2009 |
Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography.
Topics: Carcinoid Tumor; Dihydroxyphenylalanine; Fluorine Radioisotopes; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Receptors, Somatostatin; Somatostatin; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |